Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dipraglurant is a negative allosteric regulator (NAM) of blood-brain barrier transmissible mGluR5 with effective, selective and oral activity, with an IC50 value of 21 nM. Dipraglurant can treat levodopa-induced dyskinesia in Parkinson's disease (PD-LID).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約 5 days | ¥ 62,000 |
25 mg | 約6-8 週間 | ¥ 289,500 |
50 mg | 約6-8 週間 | ¥ 376,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
1 mL * 10 mM (in DMSO) | 約 5 days | ¥ 91,000 |
説明 | Dipraglurant is a negative allosteric regulator (NAM) of blood-brain barrier transmissible mGluR5 with effective, selective and oral activity, with an IC50 value of 21 nM. Dipraglurant can treat levodopa-induced dyskinesia in Parkinson's disease (PD-LID). |
ターゲット&IC50 | mGluR5:21 nM (IC50) |
別名 | ADX48621 |
分子量 | 265.29 |
分子式 | C16H12FN3 |
CAS No. | 872363-17-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (150.78 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dipraglurant 872363-17-2 Others ADX 48621 ADX48621 ADX-48621 Inhibitor inhibitor inhibit